Novartis and the Bill has announced its collaboration with Melinda Gates Foundation to discover and develop an accessible in vivo gene therapy, thus a new method of gene therapy to cure Sickle Cell Disease (SCD).
A press release issued by the Sickle Cell Foundation of Ghana indicated that the agreement with the foundation will provide funding support for the discovery and development of a single-administration.
The release added that the Pharmaceutical company will provide in-kind support and access to its suite of technologies and resources.
“Novartis will prioritize addressing access and distribution hurdles posed by limited healthcare infrastructure in low- and middle-income countries and the funding agreement includes specific provisions to support global access to any resulting innovations.”
“The agreement would further build on the Novartis commitment to improve the lives of patients with sickle cell disease through the development of new treatments, including crizanlizumab, strategic partnerships with government and non-government organizations, and support for such interventions as newborn screenings and the distribution of existing drugs, the statement disclosed.
Hematologist and President of the Novartis Institutes for BioMedical Research (NIBR), Jay Bradner, said the Pharmaceutical Company is “thrilled to have the support of the Bill & Melinda Gates Foundation in addressing this global unmet medical need.”
According to the statement, Novartis is developing the new method of gene therapy, to alleviate SCD patients from staying long in hospitals, adding that the new method is simpler than the current methods of gene therapy.
“Novartis envisions developing an accessible in vivo gene therapy for SCD that could potentially be administered once, directly to the patient, without the need to modify the cells in a lab. This would have the advantage of mitigating the need for long or repeated hospital stays or specialized lab infrastructure.”
- World Bank classifies Ghana as high debt distressed country; debt to GDP to hit 104%
- In pictures: Hundreds rendered homeless at Ashalaja
- While others mocked me, Seidu Agongo offered to help – Kofi Amoabeng
- ‘Suck a breast within October’ – Health expert advises men
- Police on manhunt for man flogging toddler in viral video
- Child Rights International places ¢10k bounty on head of man flogging toddler in viral video
- President’s son loses army post after Twitter spree
- Pay compensation to affected customers – PURC orders ECG
- E-levy: GRA blames charging entities for wrongful deductions
- ‘I sold my mansion for me not to go broke’ – Kofi Amoabeng
- President’s speech did not offer any new direction in fighting galamsey – Daryl Bosu
- Samuel Antwi beats Johnson Acquah to win the Translight Solar Tennis Super Cup
- Two sisters settling family feud on Big Chef
- Minority in Parliament pressures government to announce producer price of cocoa for 2022 season
- 25 killed as bus plunges into gorge in India
- Masloc begins training for its staff as nationwide digitisation rollout
- GFA launches Talent Identification and Development Programme
- Illegal miners torture suspected thieves on site
- Suicide is never an option – Funny Face
- #NoToGalamsey: The pledge to put my presidency on the line wasn’t bombast or recklessness – Akufo-Addo
- 2014 World Cup was problematic – Kwesi Nyantakyi
- Driving Schools Association to collaborate with MTTD to clamp down on unregistered drivers
- GOIL donates hospital beds to Asuom Health Centre in Eastern region
- Government not against mining but can’t accept ones that destroy our country – Akufo-Addo
- My government is yet to win galamsey fight – Akufo-Addo